1. Home
  2. NXPL vs PMN Comparison

NXPL vs PMN Comparison

Compare NXPL & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXPL
  • PMN
  • Stock Information
  • Founded
  • NXPL 1997
  • PMN 2004
  • Country
  • NXPL United States
  • PMN Canada
  • Employees
  • NXPL N/A
  • PMN N/A
  • Industry
  • NXPL Telecommunications Equipment
  • PMN Pharmaceuticals and Biotechnology
  • Sector
  • NXPL Telecommunications
  • PMN Health Care
  • Exchange
  • NXPL Nasdaq
  • PMN Nasdaq
  • Market Cap
  • NXPL 32.5M
  • PMN 29.8M
  • IPO Year
  • NXPL N/A
  • PMN N/A
  • Fundamental
  • Price
  • NXPL $0.98
  • PMN $0.96
  • Analyst Decision
  • NXPL
  • PMN
  • Analyst Count
  • NXPL 0
  • PMN 0
  • Target Price
  • NXPL N/A
  • PMN N/A
  • AVG Volume (30 Days)
  • NXPL 152.4K
  • PMN 42.3K
  • Earning Date
  • NXPL 11-14-2024
  • PMN 03-31-2025
  • Dividend Yield
  • NXPL N/A
  • PMN N/A
  • EPS Growth
  • NXPL N/A
  • PMN N/A
  • EPS
  • NXPL N/A
  • PMN N/A
  • Revenue
  • NXPL $66,482,000.00
  • PMN N/A
  • Revenue This Year
  • NXPL N/A
  • PMN N/A
  • Revenue Next Year
  • NXPL N/A
  • PMN N/A
  • P/E Ratio
  • NXPL N/A
  • PMN N/A
  • Revenue Growth
  • NXPL 179.89
  • PMN N/A
  • 52 Week Low
  • NXPL $0.71
  • PMN $0.87
  • 52 Week High
  • NXPL $2.68
  • PMN $2.61
  • Technical
  • Relative Strength Index (RSI)
  • NXPL 45.18
  • PMN 56.16
  • Support Level
  • NXPL $0.98
  • PMN $0.90
  • Resistance Level
  • NXPL $1.08
  • PMN $0.95
  • Average True Range (ATR)
  • NXPL 0.10
  • PMN 0.06
  • MACD
  • NXPL -0.02
  • PMN 0.01
  • Stochastic Oscillator
  • NXPL 18.75
  • PMN 67.79

About NXPL NextPlat Corp

NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine is based on the use of two complementary techniques. The company applies its thermodynamic, computational discovery platform-ProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: